ici 118551 and lapatinib

ici 118551 has been researched along with lapatinib in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Dahal, A; Gu, X; Jois, S; Mattheolabakis, G; Singh, SS; Withers, S	1

Other Studies

1 other study(ies) available for ici 118551 and lapatinib

Article	Year
A grafted peptidomimetic for EGFR heterodimerization inhibition: Implications in NSCLC models. European journal of medicinal chemistry, 2021, Apr-15, Volume: 216 Topics: Animals; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Dimerization; Drug Design; Drug Screening Assays, Antitumor; ErbB Receptors; Female; Humans; Lung Neoplasms; Mice; Mice, Nude; Peptides; Peptidomimetics; Phosphorylation; Protein Interaction Domains and Motifs; Protein Kinase Inhibitors; Transplantation, Heterologous	2021

Article

Year

A grafted peptidomimetic for EGFR heterodimerization inhibition: Implications in NSCLC models.

European journal of medicinal chemistry, 2021, Apr-15, Volume: 216

Topics: Animals; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Dimerization; Drug Design; Drug Screening Assays, Antitumor; ErbB Receptors; Female; Humans; Lung Neoplasms; Mice; Mice, Nude; Peptides; Peptidomimetics; Phosphorylation; Protein Interaction Domains and Motifs; Protein Kinase Inhibitors; Transplantation, Heterologous

2021